This research service analyzes the Brazilian healthcare system through the revenue of pharmaceutical and biotechnology drugs, medical devices, medical equipment, clinical diagnostics, and administrative clinical healthcare IT systems. It also delivers an overview of the Brazilian Unified Health System (the SUS) as well as an overview of Brazil's healthcare infrastructure with a breakdown by region and type. The research service also examines the country's private insurance plans, its demographics, and its disease burdens. Industry challenges, drivers, and restraints that are anticipated to impact the Brazilian healthcare market are given for the forecast period, which ends in 2015. Consequent growth opportunities are also analyzed.